Hong Kong Stock Market | China Tongfu (01763.HK) again rose by more than 8%. Novartis' nuclear medicine approved for listing in China is expected to ignite the domestic nuclear medicine industry.

According to the Securities Times app, China Tong Fu (01763.HK) once again rose by over 8%, with its stock price rising by over 130% so far this year. As of the time of publication, it was up by 7.94% at 24.48 Hong Kong dollars, with a trading volume of 13.0297 million Hong Kong dollars.